286 related articles for article (PubMed ID: 26977882)
1. HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.
Pei Y; Liu KW; Wang J; Garancher A; Tao R; Esparza LA; Maier DL; Udaka YT; Murad N; Morrissy S; Seker-Cin H; Brabetz S; Qi L; Kogiso M; Schubert S; Olson JM; Cho YJ; Li XN; Crawford JR; Levy ML; Kool M; Pfister SM; Taylor MD; Wechsler-Reya RJ
Cancer Cell; 2016 Mar; 29(3):311-323. PubMed ID: 26977882
[TBL] [Abstract][Full Text] [Related]
2. Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
Vollmer J; Ecker J; Hielscher T; Valinciute G; Ridinger J; Jamaladdin N; Peterziel H; van Tilburg CM; Oehme I; Witt O; Milde T
J Neurooncol; 2023 Sep; 164(3):617-632. PubMed ID: 37783879
[TBL] [Abstract][Full Text] [Related]
3. Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.
Zeuner S; Vollmer J; Sigaud R; Oppermann S; Peterziel H; ElHarouni D; Oehme I; Witt O; Milde T; Ecker J
J Neurooncol; 2024 Jan; 166(1):99-112. PubMed ID: 38184819
[TBL] [Abstract][Full Text] [Related]
4. RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification.
Ćwiek P; Leni Z; Salm F; Dimitrova V; Styp-Rekowska B; Chiriano G; Carroll M; Höland K; Djonov V; Scapozza L; Guiry P; Arcaro A
Oncotarget; 2015 Jan; 6(1):116-29. PubMed ID: 25402633
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors induce medulloblastoma cell death independent of HDACs recruited in REST repression complexes.
Alshawli AS; Wurdak H; Wood IC; Ladbury JE
Mol Genet Genomic Med; 2020 Oct; 8(10):e1429. PubMed ID: 32720471
[TBL] [Abstract][Full Text] [Related]
6. HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors?
Shofuda T; Kanemura Y
Neuro Oncol; 2021 Feb; 23(2):173-174. PubMed ID: 33394043
[No Abstract] [Full Text] [Related]
7. Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition.
Graziani V; Garcia AR; Alcolado LS; Le Guennec A; Henriksson MA; Conte MR
Sci Rep; 2023 Jan; 13(1):1273. PubMed ID: 36690651
[TBL] [Abstract][Full Text] [Related]
8. OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma.
Xu Z; Murad N; Malawsky D; Tao R; Rivero-Hinojosa S; Holdhof D; Schüller U; Zhang P; Lazarski C; Rood BR; Packer R; Gershon T; Pei Y
Clin Cancer Res; 2022 Oct; 28(19):4278-4291. PubMed ID: 35736214
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma.
Chan TSY; Picard D; Hawkins CE; Lu M; Pfister S; Korshunov A; Roussel MF; Wechsler-Reya RJ; Henkin J; Bouffet E; Huang A
Neurooncol Adv; 2021; 3(1):vdab002. PubMed ID: 33629064
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma.
Zhang S; Gong Z; Oladimeji PO; Currier DG; Deng Q; Liu M; Chen T; Li Y
Exp Hematol Oncol; 2019; 8():30. PubMed ID: 31788346
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Regulation of Protein Synthesis by Mediator Kinase in MYC-driven Medulloblastoma.
Wang D; Ritz C; Pierce A; Brunt B; Luo Y; Dahl N; Venkataraman S; Danis E; Kuś K; Mazan M; Rzymski T; Veo B; Vibhakar R
bioRxiv; 2024 Mar; ():. PubMed ID: 38559100
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL
Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285
[TBL] [Abstract][Full Text] [Related]
13. Targeting HDAC And PI3K Inhibits MYC-Driven Medulloblastoma Growth.
Cancer Discov; 2016 May; 6(5):OF10. PubMed ID: 27012830
[TBL] [Abstract][Full Text] [Related]
14. Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Cavalli FMG; Remke M; Rampasek L; Peacock J; Shih DJH; Luu B; Garzia L; Torchia J; Nor C; Morrissy AS; Agnihotri S; Thompson YY; Kuzan-Fischer CM; Farooq H; Isaev K; Daniels C; Cho BK; Kim SK; Wang KC; Lee JY; Grajkowska WA; Perek-Polnik M; Vasiljevic A; Faure-Conter C; Jouvet A; Giannini C; Nageswara Rao AA; Li KKW; Ng HK; Eberhart CG; Pollack IF; Hamilton RL; Gillespie GY; Olson JM; Leary S; Weiss WA; Lach B; Chambless LB; Thompson RC; Cooper MK; Vibhakar R; Hauser P; van Veelen MC; Kros JM; French PJ; Ra YS; Kumabe T; López-Aguilar E; Zitterbart K; Sterba J; Finocchiaro G; Massimino M; Van Meir EG; Osuka S; Shofuda T; Klekner A; Zollo M; Leonard JR; Rubin JB; Jabado N; Albrecht S; Mora J; Van Meter TE; Jung S; Moore AS; Hallahan AR; Chan JA; Tirapelli DPC; Carlotti CG; Fouladi M; Pimentel J; Faria CC; Saad AG; Massimi L; Liau LM; Wheeler H; Nakamura H; Elbabaa SK; Perezpeña-Diazconti M; Chico Ponce de León F; Robinson S; Zapotocky M; Lassaletta A; Huang A; Hawkins CE; Tabori U; Bouffet E; Bartels U; Dirks PB; Rutka JT; Bader GD; Reimand J; Goldenberg A; Ramaswamy V; Taylor MD
Cancer Cell; 2017 Jun; 31(6):737-754.e6. PubMed ID: 28609654
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
Phoenix TN; Patmore DM; Boop S; Boulos N; Jacus MO; Patel YT; Roussel MF; Finkelstein D; Goumnerova L; Perreault S; Wadhwa E; Cho YJ; Stewart CF; Gilbertson RJ
Cancer Cell; 2016 Apr; 29(4):508-522. PubMed ID: 27050100
[TBL] [Abstract][Full Text] [Related]
16. Evasion of Cell Senescence Leads to Medulloblastoma Progression.
Tamayo-Orrego L; Wu CL; Bouchard N; Khedher A; Swikert SM; Remke M; Skowron P; Taylor MD; Charron F
Cell Rep; 2016 Mar; 14(12):2925-37. PubMed ID: 26997276
[TBL] [Abstract][Full Text] [Related]
17. The whole-genome landscape of medulloblastoma subtypes.
Northcott PA; Buchhalter I; Morrissy AS; Hovestadt V; Weischenfeldt J; Ehrenberger T; Gröbner S; Segura-Wang M; Zichner T; Rudneva VA; Warnatz HJ; Sidiropoulos N; Phillips AH; Schumacher S; Kleinheinz K; Waszak SM; Erkek S; Jones DTW; Worst BC; Kool M; Zapatka M; Jäger N; Chavez L; Hutter B; Bieg M; Paramasivam N; Heinold M; Gu Z; Ishaque N; Jäger-Schmidt C; Imbusch CD; Jugold A; Hübschmann D; Risch T; Amstislavskiy V; Gonzalez FGR; Weber UD; Wolf S; Robinson GW; Zhou X; Wu G; Finkelstein D; Liu Y; Cavalli FMG; Luu B; Ramaswamy V; Wu X; Koster J; Ryzhova M; Cho YJ; Pomeroy SL; Herold-Mende C; Schuhmann M; Ebinger M; Liau LM; Mora J; McLendon RE; Jabado N; Kumabe T; Chuah E; Ma Y; Moore RA; Mungall AJ; Mungall KL; Thiessen N; Tse K; Wong T; Jones SJM; Witt O; Milde T; Von Deimling A; Capper D; Korshunov A; Yaspo ML; Kriwacki R; Gajjar A; Zhang J; Beroukhim R; Fraenkel E; Korbel JO; Brors B; Schlesner M; Eils R; Marra MA; Pfister SM; Taylor MD; Lichter P
Nature; 2017 Jul; 547(7663):311-317. PubMed ID: 28726821
[TBL] [Abstract][Full Text] [Related]
18. DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.
Hanaford AR; Archer TC; Price A; Kahlert UD; Maciaczyk J; Nikkhah G; Kim JW; Ehrenberger T; Clemons PA; Dančík V; Seashore-Ludlow B; Viswanathan V; Stewart ML; Rees MG; Shamji A; Schreiber S; Fraenkel E; Pomeroy SL; Mesirov JP; Tamayo P; Eberhart CG; Raabe EH
Clin Cancer Res; 2016 Aug; 22(15):3903-14. PubMed ID: 27012813
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.
Oh S; Flynn RA; Floor SN; Purzner J; Martin L; Do BT; Schubert S; Vaka D; Morrissy S; Li Y; Kool M; Hovestadt V; Jones DT; Northcott PA; Risch T; Warnatz HJ; Yaspo ML; Adams CM; Leib RD; Breese M; Marra MA; Malkin D; Lichter P; Doudna JA; Pfister SM; Taylor MD; Chang HY; Cho YJ
Oncotarget; 2016 May; 7(19):28169-82. PubMed ID: 27058758
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms and therapeutic targets in pediatric brain tumors.
Liu KW; Pajtler KW; Worst BC; Pfister SM; Wechsler-Reya RJ
Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
